title: Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis.
authors.forename: M
authors.initials: M
authors.lastname: Bojar
authors.forename: M
authors.initials: M
authors.lastname: Zajac
authors.forename: E
authors.initials: E
authors.lastname: Meluzínová
authors.forename: E
authors.initials: E
authors.lastname: Houžvičková
authors.forename: J
authors.initials: J
authors.lastname: Libertinová
authors.forename: P
authors.initials: P
authors.lastname: Lišková
authors.forename: V
authors.initials: V
authors.lastname: Mat'oška
authors.forename: O
authors.initials: O
authors.lastname: Nyč
authors.forename: M
authors.initials: M
authors.lastname: Mináriková
mesh_terms: D057134:Antibodies, Neutralizing / Q000097:blood* / Q000276:immunology; D001379:Azathioprine / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016899:Interferon-beta / Q000276:immunology / Q000627:therapeutic use*; D008775:Methylprednisolone / Q000627:therapeutic use*; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000097:blood / Q000188:drug therapy / Q000276:immunology*
chemical_list: D057134:Antibodies, Neutralizing; D007166:Immunosuppressive Agents; D016899:Interferon-beta; D001379:Azathioprine; D008775:Methylprednisolone